Case Studies

Epidemiological Study of Hidradenitis Suppurativa (HS) in Australian Population

One of the most rigorous and largest general population-based HS epidemiological studies reported thus far, for the first time sheds light on the prevalence and impact of HS in Australia as well as the demographic characteristics of the sufferers.   SITUATION A large global pharmaceutical company was seeking a partner for a cross-sectional, observational, population-based […]

Read More

January 15th, 2020

New Formulation ROTAVAC 5C Has the Lowest Cold Chain Footprint Amongst Oral Rotavirus Vaccine in the World.

Seamless coordination of complex pediatric Phase III clinical trial for ROTAVAC 5C® in India brings world closer to improving the global supply of affordable rotavirus vaccines.   SITUATION George Clinical was selected by sponsor Bharat Biotech to conduct a seamless, sequential Phase III, randomized, multi-center, single-blind study to evaluate immunogenicity, safety and reactogenicity of liquid […]

Read More

October 9th, 2019

George Clinical leads China Component and Recruitment in World-First Large CPAP Device Trial

The Study Although Obstructive sleep apnea (OSA) is a very common condition that is associated with an increased risk of cardiovascular disease (CVD), there is much uncertainty over the effectiveness of treatment with nasal continuous positive airway pressure (CPAP) for the prevention of CVD. The SAVE trial was a multi-centre, open label, parallel, prospective, randomised, […]

Read More

June 20th, 2017

George Clinical Scientific Leaders boost recruitment for Phase 1 Patient Study

Utilizing key therapeutic knowledge leader networks as championed by George Clinical has again shown its effectiveness in boosting recruitment; this time for a Phase 1 renal patient trial. It is widely understood that the recruitment of patients into a Phase 1 trial can be fraught with difficulty. This difficulty arises from: A lack of established […]

Read More

January 23rd, 2017

Scientific Leadership: Our Communication Framework

Background George Clinical provides scientific leadership to clinical trials, where peer-to-peer engagement from clinicians is leveraged to facilitate study operations. In the traditional study operations model, clinical research associates (CRAs) typically engage with site personnel, such as study coordinators, on a day-to-day basis. Principal investigators, whose expertise and seniority at the site’s operational hierarchy, is […]

Read More

January 23rd, 2017

Renal Health: Recruitment Success in the Asia-Pacific

The Study George Clinical (GC)is collaborating with a global, research-based biopharmaceutical company to evaluate the effect of a new chemical entity in subjects with type 2 diabetes and nephropathy. George Clinical services GC is responsible for project management (PM) and monitoring throughout the Asia-Pacific. Other regions were managed by a separate contract research organization (CRO). […]

Read More

January 23rd, 2017

Oncology: Recruitment Success in China

The Study George Clinical (GC) collaborated with a mid-sized global pharmaceutical company to conduct a randomized trial comparing pain relief medication for patients with moderate to severe chronic cancer pain. George Clinical services GC was responsible for project management (PM) and monitoring across 26 sites in China. Study sites were located in Beijing, Changchun, Dalian, […]

Read More

January 23rd, 2017

Oncology: Multiple services; one provider

With the support of George Clinical (GC), The George Institute (TGI) for Global Health conducted a longitudinal cohort study of approximately 9,500 hospital patients with a first time diagnosis of cancer. The study was conducted across eight countries, namely: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Thailand and Vietnam. The aim of the study was to […]

Read More

June 22nd, 2016

George Clinical Awarded Contract for Clinical Trial Management Services on Rotavirus Vaccine

George Clinical has recently been awarded the contract for full service clinical trial management services for a clinical study that seeks to improve the formulation further and also the current administration challenges for a rotavirus vaccine. The vaccine was recently launched by Indian Prime Minister Narendra Modi and developed by a Hyderabad based healthcare organization […]

Read More

June 21st, 2016

Outstanding metrics achieved for a Phase III diabetes study in China

The World Health Organization estimates that 347 million people worldwide have diabetes, and that number is expected to continue increasing as more people move to urban cities and the population ages. Low and middle-income countries, like China and India, have been hit hardest with this disease and other NCDs. In 2010, the total number of […]

Read More

June 21st, 2016
George Clinical

customerservice@georgeclinical.com

Profits from George Clinical support the work of The George Institute for Global Health.

Join our Mailing List

Add George Clinical to your network